The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ABT FINANCIAL STATEMENTS

Abbott Laboratories — balance sheet, income statement and cash flow trends

ABTAbbott Laboratories

🇺🇸 USA · US · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
020 B40 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue46.6 B $Gross Profit26.5 B $ · 57%Operating Income7.9 B $ · 17%Pre-tax Income7.5 B $ · 16%Net Income to Owners5.4 B $ · 12%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue46.6 B $+8.1%
Gross Profit26.5 B $+16.3%
Operating Income7.9 B $+5.1%
EBITDA9.9 B $-14.4%
Net Income to Owners5.4 B $-61.2%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
050 B100 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets109.2 B
  • Equity51.1 B $47%
  • Current Liabilities17.8 B $16%
  • Long-term Liabilities39.6 B $37%

Key Figures

YoY change
Total Assets109.2 B $+30.0%
Total Liabilities57.5 B $+73.2%
Total Equity51.1 B $+1.1%
Cash & ST Investments5.6 B $-23.1%
Total Debt32.6 B $+142.7%
Net Debt27.5 B $+324.1%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
05 B10 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-10 B010 B9.9 B $Operating-22.4 B $Investing10.6 B $Financing-1.8 B $Net Change

Key Figures

YoY change
Operating Cash Flow9.9 B $+9.6%
Capital Expenditures2 B $-12.3%
Free Cash Flow8.7 B $+28.7%
Dividends Paid-4.3 B $-207.2%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ABT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 4, 26. This content is for informational purposes only and is not investment advice.